Avalon Globocare Corp (NASDAQ:ALBT)
| 0.50 Delayed Data As of Nov 29 |  -0.019 / -3.66%Today’s Change | 0.46 Today|||52-Week Range 6.05 | -90.38% Year-to-Date |
Latest ALBT News | Press Releases
No recent news for Avalon Globocare Corp.
Today’s Trading
| Previous close | 0.52 |
| Today’s open | 0.50 |
| Day’s range | 0.50 - 0.50 |
| Volume | 190 |
| Average volume (3 months) | 53,920 |
| Market cap | $5.4M |
Data as of 12:34pm ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -19.47% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -13.57% |
| P/E ratio | NM |
| Price/Sales | 40.35 |
| Price/Book | 2.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| UBXUNITY Biotechnology ... | -0.01 | -0.76% |
| ASLNAslan Pharmaceutical... | +0.02 | +2.26% |
| ITRMIterum Therapeutics ... | -0.06 | -2.76% |
| MGTXMeiraGTx Holdings PL... | -0.04 | -0.74% |
Data as of 4:00pm ET, 11/29/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$11.9M |
| Net profit margin | -992.44% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Freehold, New Jersey |
Forecasts
